SynthesisFrontiers in endocrinology2021

Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Yuan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.